InvestorsHub Logo
Followers 66
Posts 12688
Boards Moderated 0
Alias Born 06/03/2015

Re: Talon38 post# 450754

Sunday, 02/04/2024 8:02:58 PM

Sunday, February 04, 2024 8:02:58 PM

Post# of 459815
For those who don't know by now... it's not a true "market" we're dealing with, especially in biotech. It's run by a collusive network that includes HFs & MMs who collectively manage the price. For their smokescreen, they employ the services of so-called "journalists" (like AF) to produce fake news about certain targeted biotechs... along with the efforts of dozens of hired social-media FUDsters to troll msg brds and spew negative nonsense. I think everyone has seen the list.
Many investors and observers have their suspicions and beliefs that these HFs/MMs also have their hands in BP's pocket. It certainly benefits BP if promising companies can be bought at the cheap... saving them a few $billion.

Refer to Xena's post about an analyst's perspective with NWBO... It's not just unique to AVXL.

First, the tactics are well known; use loose associations with mobster like Hedge Funds, who’s CEOs, Board Members, etc. are insider 1%’ers. Hire FUDsters on social media and sites like this to create confusion amongst the ranks, manipulating the emotions of retail investors before the Funds arrive to keep the price low and make sentiment among the public skeptical and on guard. The use of insiders in government by Pharma with incentives to keep status quo in place is well documented. It doesn’t even have to be overt, simply keep the public’s eye on something other than the reality.

The Pharma industry has benefited from taxpayer funded scientific research since Penicillin was discovered. And if they don’t get what they want from emerging new players in the space they go to the mob tactic; intimidate, drop the share price to force shitty deals with predatory lenders, then keep the narrative on what bad actors the company are for having by done so.

The tactic will be the same; throw doubt on the trial results relentlessly. They’ll say that using an outside comparator is not the “gold standard” and find top scientists to say the same for a price. They’ll question things that other scientists and people who understand science take for granted as normal, and try to keep the price down to avoid NWBO uplisting to bring on substantial larger Fund investment. They’ll question the change in the SAP and want to know why the PFS was abandoned using confusing language to the commoner that the scientists will have to address again and again and again to prevent the public from their inherent doubts fostered over the past 10 years by social media. They’ll take up the same narrative exwannabe, learningcurve, and others have recently used to imply Advent will profit while NWBO holds the bag, that NWBO is nothing but a shell company that used a ruse of curing cancer to fleece naive retail investors, etc.

The fact is the company has the upper hand now. One should understand this by their quietness; strong hands don’t need to talk. That’s all anyone needs to know. To think anything other than this shows inexperience with success

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News